0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Toxicology
 61-63 of 63 Articles
Article |  FREE
Teresa G. Holtrop, MD; Hugh Y. Yee, PhD; Pippa M. Simpson, PhD; et al.
Arch Pediatr Adolesc Med. 1998;152(5):455-458. doi:10.1001/archpedi.152.5.455.

Article |  FREE
Eugene Mowad, MD; Ibrahim Haddad, MD; David J. Gemmel, MA
Arch Pediatr Adolesc Med. 1998;152(5):485-488. doi:10.1001/archpedi.152.5.485.

Article |  FREE
Stanley J. Schaffer, MD, MS; James R. Campbell, MD, MPH; Peter G. Szilagyi, MD, MPH; et al.
Arch Pediatr Adolesc Med. 1998;152(2):185-189. doi:10.1001/archpedi.152.2.185.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Dermatology
Original Investigation  | 
Cutaneous Toxic Effects of BRAF Inhibitors Alone and in Combination With MEK Inhibitors for Metastatic Melanoma
Giuliana Carlos, MBBS; Rachael Anforth, BMed; Arthur Clements, BSc (Med), MBBS; et al.
JAMA
Capitol Health Call  | 
Washington Shines a Light on Opioid Overdose
Laura Buchholz
JAMA Ophthalmology
Observation  | 
Severe Conjunctival Reaction Following Attempted Corneal Tattooing
Sayali Pradhan, MD, FICO; Manoranjan Das, MD; Arun Kumar Panigrahi, MD; et al.
JAMA Oncology
Brief Report  | 
Nephrotoxicity of the BRAF Inhibitors Vemurafenib and Dabrafenib
Kenar D. Jhaveri, MD; Vipulbhai Sakhiya, MBBS; Steven Fishbane, MD